{
    "organizations": [],
    "uuid": "d5993a4eee650530e616e0734f915cd5a4388124",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-emerald-health-therapeutics-report/brief-emerald-health-therapeutics-reports-qtrly-loss-per-share-c0-04-idUSASC09UFL",
    "ord_in_thread": 0,
    "title": "BRIEF-Emerald Health Therapeutics Reports Qtrly Loss Per Share C$0.04​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Emerald Health Therapeutics Inc:\n* EMERALD HEALTH THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* QTRLY LOSS PER SHARE C$0.04​ * HAD ABOUT $89 MILLION IN CASH AND CASH EQUIVALENTS AS AT MARCH 29, 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-04-02T20:34:00.000+03:00",
    "crawled": "2018-04-03T16:11:57.040+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "emerald",
        "health",
        "therapeutic",
        "inc",
        "emerald",
        "health",
        "therapeutic",
        "report",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "qtrly",
        "loss",
        "per",
        "share",
        "c",
        "million",
        "cash",
        "cash",
        "equivalent",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}